oral curcumin alzheimer's disease tolerability efficacy num week randomized double blind placebo-controlled study abstract introduction curcumin polyphenolic compound derived plant curcuma long lin demonstrated antioxidant anti-inflammatory effects effects reducing beta-amyloid aggregation reduces pathology transgenic models alzheimer's disease ad promising candidate treating human ad purpose current study generate tolerability preliminary clinical biomarker efficacy data curcumin persons ad methods performed num week randomized double blind placebo-controlled study curcumin num complex open-label extension num weeks thirty-six persons mild-to-moderate ad randomized receive placebo num grams/day num grams/day oral curcumin num weeks weeks num num subjects receiving curcumin continued dose subjects previously receiving placebo randomized num ratio num grams/day num grams/day primary outcome measures incidence adverse events clinical laboratory tests alzheimer's disease assessment scale cognitive subscale adas-cog num weeks completing study secondary outcome measures included neuropsychiatric inventory npi alzheimer's disease cooperative study activities daily living adcs-adl scale levels num num plasma levels num t-tau p-tau num num isoprostanes cerebrospinal fluid plasma levels curcumin metabolites hours drug administration measured results age completers num num years mini-mental status examination mmse score num subject withdrew placebo num worsened memory num subjects withdrew curcumin group num due gastrointestinal symptoms curcumin num complex lowered hematocrit increased glucose levels clinically insignificant differences treatment groups clinical biomarker efficacy measures levels native curcumin measured plasma low num ng/ml conclusions curcumin generally well-tolerated subjects curcumin withdrew due gastrointestinal symptoms unable demonstrate clinical biochemical evidence efficacy curcumin num complex ad num week placebo-controlled trial preliminary data suggest limited bioavailability compound trial registration clinicaltrials gov identifier nct num 
